Home
|
Inbox
|
Search
|
Event
P361 LAMA/LABA Glycopyrrolate/Formoterol Fixed-Dose Combination, Delivered Using a Novel MDI Co-Suspension ™ Delivery Technology Reduces Risk of Clinically Important Deteriorations in COPD Versus Placebo and Monocomponent MDIs
Monday
May
22
9:15 AM
4:15 PM
Type : Scientific Abstract |
Speaker(s)
|
Home
|
Inbox
|
Search
|